{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:25Z","timestamp":1790140405725,"version":"4.0.1"},"reference-count":285,"publisher":"Elsevier","isbn-type":[{"value":"9780128177303","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.irn.2019.10.004","type":"book-chapter","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T18:43:27Z","timestamp":1574361807000},"page":"137-192","source":"Crossref","is-referenced-by-count":124,"title":["Multiple system atrophy"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","article-title":"CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease","volume":"28","author":"Abdo","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mds.10714","article-title":"Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease","volume":"19","author":"Abdo","year":"2004","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.parkreldis.2007.02.002","article-title":"CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy","volume":"13","author":"Abdo","year":"2007","journal-title":"Parkinsonism and Related Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00415-003-0248-4","article-title":"Olfactory dysfunction in cerebellar ataxia and multiple system atrophy","volume":"250","author":"Abele","year":"2003","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000131165","article-title":"Nigro-striate and cerebello-nigro-striate degeneration. (Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type","volume":"142","author":"Adams","year":"1961","journal-title":"Psychiatria et Neurologia"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.12.001","article-title":"CSF alpha-synuclein does not differentiate between parkinsonian disorders","volume":"33","author":"Aerts","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","article-title":"The neuropathology, pathophysiology and\u00a0genetics of multiple system atrophy","volume":"38","author":"Ahmed","year":"2012","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib8","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","article-title":"Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy","volume":"4","author":"Al-Chalabi","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"Backstrom","year":"2015","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nicl.2016.07.004","article-title":"Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses","volume":"12","author":"Badoud","year":"2016","journal-title":"Neuroimage Clinical"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"e0189897","DOI":"10.1371\/journal.pone.0189897","article-title":"Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis","volume":"12","author":"Bajaj","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.26471","article-title":"Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease","volume":"31","author":"Barbagallo","year":"2016","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib13","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.27041","article-title":"Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy","volume":"32","author":"Bassil","year":"2017","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/mds.27450","article-title":"Young-onset multiple system atrophy: Clinical and pathological features","volume":"33","author":"Batla","year":"2018","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mds.20450","article-title":"Depressive symptoms and life satisfaction in patients with multiple system atrophy","volume":"20","author":"Benrud-Larson","year":"2005","journal-title":"Movement Disorders"},{"issue":"Pt 1","key":"10.1016\/bs.irn.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/brain\/awn291","article-title":"Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS study","volume":"132","author":"Bensimon","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson's disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archneur.59.5.835","article-title":"Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: A diagnostic algorithm","volume":"59","author":"Bhattacharya","year":"2002","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","article-title":"Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension","volume":"17","author":"Biaggioni","year":"2017","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib21","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1212\/01.wnl.0000249307.59950.f8","article-title":"Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI","volume":"67","author":"Blain","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.72.3.300","article-title":"Dystonia in multiple system atrophy","volume":"72","author":"Boesch","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-199502000-00012","article-title":"Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: A controlled study of acute administration","volume":"18","author":"Bordet","year":"1995","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00002826-199408000-00010","article-title":"Octreotide in the management of orthostatic hypotension in multiple system atrophy: Pilot trial of chronic administration","volume":"17","author":"Bordet","year":"1994","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/bs.irn.2019.10.004_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2018.06.015","article-title":"Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study","volume":"56","author":"Borm","year":"2018","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.autneu.2017.12.006","article-title":"Multiple system atrophy: Building a global community - 30 years of advocacy efforts","volume":"211","author":"Bower","year":"2018","journal-title":"Autonomic Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2019.10.004_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0002-8703(25)90007-5","article-title":"Postural hypotension. A report of three cases","volume":"1","author":"Bradbury","year":"1925","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/jnnp.2006.092833","article-title":"Pupil findings in a consecutive series of 150 patients with generalised autonomic neuropathy","volume":"77","author":"Bremner","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2019.10.004_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in Neurology: A systematic review and meta-analysis","author":"Bridel","year":"2019","journal-title":"JAMA Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jnnp.52.8.962","article-title":"The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine","volume":"52","author":"Brooks","year":"1989","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mds.22413","article-title":"Proposed neuroimaging criteria for the diagnosis of multiple system atrophy","volume":"24","author":"Brooks","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.irn.2018.08.006","article-title":"SPECT molecular imaging in atypical parkinsonism","volume":"142","author":"Brumberg","year":"2018","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2019.10.004_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","article-title":"A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","volume":"1326","author":"Bukhatwa","year":"2010","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archneur.62.6.981","article-title":"Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia","volume":"62","author":"Burk","year":"2005","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mds.1107","article-title":"Pontine MRI hyperintensities (\"the cross sign\") are not pathognomonic for multiple system atrophy (MSA)","volume":"16","author":"Burk","year":"2001","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00415-018-9121-3","article-title":"An update on advances in magnetic resonance imaging of multiple system atrophy","volume":"266","author":"Chelban","year":"2019","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3988\/jcn.2008.4.1.23","article-title":"Association between parkinsonism and participation in agriculture in Korea","volume":"4","author":"Cho","year":"2008","journal-title":"Journal of Clinical Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study","volume":"257","author":"Colosimo","year":"2010","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00702-005-0379-0","article-title":"Management of multiple system atrophy: State of the art","volume":"112","author":"Colosimo","year":"2005","journal-title":"Journal of Neural Transmission"},{"issue":"15","key":"10.1016\/bs.irn.2019.10.004_bib41","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/mds.21578","article-title":"Levodopa responsiveness in disorders with parkinsonism: A review of the literature","volume":"22","author":"Constantinescu","year":"2007","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.26864","article-title":"Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction","volume":"32","author":"Coon","year":"2017","journal-title":"Movement Disorders"},{"issue":"Pt 8","key":"10.1016\/bs.irn.2019.10.004_bib44","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.25407","article-title":"Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease","volume":"28","author":"Dams","year":"2013","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","article-title":"REM sleep behaviour disorder","volume":"4","author":"Dauvilliers","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00415-006-0425-3","article-title":"Effects of daily water drinking on orthostatic and postprandial hypotension in patients with multiple system atrophy","volume":"254","author":"Deguchi","year":"2007","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A randomized trial of deep-brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2010.04.020","article-title":"Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach","volume":"39","author":"van Dijk","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mds.22732","article-title":"Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)","volume":"25","author":"Dodel","year":"2010","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib51","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.26293","article-title":"Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy","volume":"30","author":"Doppler","year":"2015","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib52","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","article-title":"Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration","volume":"38","author":"Doty","year":"1988","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/CCLM.2011.077","article-title":"\u03b1-Synuclein in Parkinson disease and other neurodegenerative disorders","volume":"49","author":"Eller","year":"2011","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib55","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mds.27635","article-title":"Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease","volume":"34","author":"Fanciulli","year":"2019","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mdc3.12270","article-title":"Elastic abdominal binders attenuate orthostatic hypotension in Parkinson's disease","volume":"3","author":"Fanciulli","year":"2016","journal-title":"Movement disorders clinical practice"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clinical Autonomic Research"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-013-0216-8","article-title":"SHC2 gene copy number in multiple system atrophy (MSA)","volume":"24","author":"Ferguson","year":"2014","journal-title":"Clinical Autonomic Research"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib61","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.25927","article-title":"Multiple system atrophy: Prognostic indicators of survival","volume":"29","author":"Figueroa","year":"2014","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285610375328","article-title":"Multiple system atrophy: Current and future approaches to management","volume":"3","author":"Flabeau","year":"2010","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib63","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3174\/ajnr.A2865","article-title":"Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging","volume":"32","author":"Focke","year":"2011","journal-title":"AJNR American Journal of Neuroradiology."},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2967\/jnumed.109.071811","article-title":"The value of the dopamine D2\/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes","volume":"51","author":"la Fougere","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"issue":"Suppl. 4","key":"10.1016\/bs.irn.2019.10.004_bib65","article-title":"Investigation and management of neurogenic bladder dysfunction","volume":"74","author":"Fowler","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib66","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Clinical practice. Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(08)70067-X","article-title":"The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study","volume":"7","author":"Gaenslen","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.parkreldis.2010.01.002","article-title":"Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study","volume":"16","author":"Gama","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jocn.2017.10.028","article-title":"Ocular features of multiple system atrophy","volume":"47","author":"Garcia","year":"2018","journal-title":"Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.sleep.2004.10.002","article-title":"Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: Long-term acceptance","volume":"6","author":"Ghorayeb","year":"2005","journal-title":"Sleep Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.juro.2009.06.023","article-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy","volume":"182","author":"Giannantoni","year":"2009","journal-title":"The Journal of Urology"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.004_bib72","doi-asserted-by":"crossref","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","article-title":"The natural history of idiopathic autonomic failure: The IAF-BO cohort study","volume":"91","author":"Giannini","year":"2018","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.004_bib73","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0000000000003156","article-title":"Early stridor onset and stridor treatment predict survival in 136 patients with MSA","volume":"87","author":"Giannini","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy. American autonomic society and American academy of neurology","volume":"8","author":"Gilman","year":"1998","journal-title":"Clinical Autonomic Research"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib75","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.23972","article-title":"Olfaction in pathologically proven patients with multiple system atrophy","volume":"27","author":"Glass","year":"2012","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib77","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00259-010-1681-0","article-title":"A novel computer-assisted image analysis of [123I]\u03b2-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders","volume":"38","author":"Goebel","year":"2011","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10286-018-0547-6","article-title":"Roles of cardiac sympathetic neuroimaging in autonomic medicine","volume":"28","author":"Goldstein","year":"2018","journal-title":"Clinical Autonomic Research"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib79","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","article-title":"Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy","volume":"32","author":"Graham","year":"1969","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib81","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/mds.23776","article-title":"Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by \u03b1-synuclein triplication (Iowa kindred)","volume":"26","author":"Gwinn","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib82","first-page":"167038","article-title":"Clinical utility of skin biopsy in differentiating between Parkinson's disease and multiple system Atrophy","volume":"2015","author":"Haga","year":"2015","journal-title":"Parkinsons Disease"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathologica"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib84","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib86","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.64.4.545","article-title":"Multiplex families with multiple system atrophy","volume":"64","author":"Hara","year":"2007","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JPD-171134","article-title":"ADS-5102 (amantadine) Extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 2 study): Interim results of an open-label safety study","volume":"7","author":"Hauser","year":"2017","journal-title":"Journal of Parkinson's Disease"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib88","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","article-title":"Magnetic resonance imaging for the diagnosis of Parkinson's disease","volume":"124","author":"Heim","year":"2017","journal-title":"Journal of Neural Transmission"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib89","doi-asserted-by":"crossref","first-page":"FNL24","DOI":"10.2217\/fnl-2018-0045","article-title":"Imaging markers of disease progression in multiple system atrophy","volume":"14","author":"Heim","year":"2019","journal-title":"Future Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.irn.2018.08.010","article-title":"Structural imaging in atypical parkinsonism","volume":"142","author":"Heim","year":"2018","journal-title":"International Review of Neurobiology"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.004_bib91","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","article-title":"[(1)(8)F]FDG-PET is superior to [(1)(2)(3)I]IBZM-SPECT for the differential diagnosis of parkinsonism","volume":"79","author":"Hellwig","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib92","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/ene.12394","article-title":"Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: A head-to-head comparison","volume":"21","author":"Hellwig","year":"2014","journal-title":"European Journal of Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fneur.2015.00091","article-title":"CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders","volume":"6","author":"Herbert","year":"2015","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.parkreldis.2013.09.003","article-title":"CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls","volume":"20","author":"Herbert","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib95","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson's disease","volume":"10","author":"He","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib96","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/mds.21501","article-title":"Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study","volume":"22","author":"Holmberg","year":"2007","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1353-8020(00)00083-3","article-title":"CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes","volume":"8","author":"Holmberg","year":"2001","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib99","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00415-002-0734-0","article-title":"Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?","volume":"249","author":"Horimoto","year":"2002","journal-title":"Journal of Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.26715","article-title":"Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification","volume":"31","author":"Huppertz","year":"2016","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib101","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib102","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12311-013-0531-6","article-title":"Consensus paper: Management of degenerative cerebellar disorders","volume":"13","author":"Ilg","year":"2014","journal-title":"The Cerebellum"},{"issue":"22","key":"10.1016\/bs.irn.2019.10.004_bib103","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0b013e3181c33adf","article-title":"Intensive coordinative training improves motor performance in degenerative cerebellar disease","volume":"73","author":"Ilg","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib104","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jnnp-2011-301068","article-title":"Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests","volume":"83","author":"Iodice","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11940-007-0020-7","article-title":"Sleep and breathing in multiple system atrophy","volume":"9","author":"Iranzo","year":"2007","journal-title":"Current Treatment Options in Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib106","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","article-title":"Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD","volume":"65","author":"Iranzo","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib108","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.WNL.0000137043.76383.A4","article-title":"Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy","volume":"63","author":"Iranzo","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1789.2007.00855.x","article-title":"Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system)","volume":"28","author":"Ishizawa","year":"2008","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/neup.12092","article-title":"Definite familial multiple system atrophy with unknown genetics","volume":"34","author":"Itoh","year":"2014","journal-title":"Neuropathology"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib111","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00234-017-1870-7","article-title":"Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping","volume":"59","author":"Ito","year":"2017","journal-title":"Neuroradiology"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib112","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/mds.20211","article-title":"Occupational therapy in multiple system atrophy: A pilot randomized controlled trial","volume":"19","author":"Jain","year":"2004","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib114","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib115","series-title":"Multiple system atrophy","first-page":"17","article-title":"Neuropathology","author":"Jellinger","year":"2014"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib116","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/14737175.2017.1392239","article-title":"Potential clinical utility of multiple system atrophy biomarkers","volume":"17","author":"Jellinger","year":"2017","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib117","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3233\/JAD-170397","article-title":"Multiple system Atrophy: An oligodendroglioneural Synucleinopathy 1","volume":"62","author":"Jellinger","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"Suppl. 12","key":"10.1016\/bs.irn.2019.10.004_bib118","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/mds.20537","article-title":"Grading of neuropathology in multiple system atrophy: Proposal for a novel scale","volume":"20","author":"Jellinger","year":"2005","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib119","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of \u03b1-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Reports"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib121","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"Natural history of pure autonomic failure: A United States prospective cohort","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib122","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib123","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3988\/jcn.2019.15.2.135","article-title":"Alpha-synuclein in skin nerve fibers as a biomarker for \u03b1-synucleinopathies","volume":"15","author":"Kim","year":"2019","journal-title":"Journal of Clinical Neurology"},{"issue":"19","key":"10.1016\/bs.irn.2019.10.004_bib125","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.0000000000000965","article-title":"Should genetic testing for SCAs be included in the diagnostic workup for MSA?","volume":"83","author":"Kim","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib126","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/mds.23659","article-title":"Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders","volume":"26","author":"King","year":"2011","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib127","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1756287213510962","article-title":"Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice","volume":"6","author":"Knuepfer","year":"2014","journal-title":"Therapeutic advances in urology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: An autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"15","key":"10.1016\/bs.irn.2019.10.004_bib130","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry","volume":"25","author":"Kollensperger","year":"2010","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib131","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/mds.21992","article-title":"Red flags for multiple system atrophy","volume":"23","author":"Kollensperger","year":"2008","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib132","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mds.10466","article-title":"Olfactory bulb in multiple system atrophy","volume":"18","author":"Kovacs","year":"2003","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib133","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.11.010","article-title":"Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism","volume":"35","author":"Krismer","year":"2017","journal-title":"Parkinsonism & Related Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib134","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.27669","article-title":"Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis","volume":"34","author":"Krismer","year":"2019","journal-title":"Movement Disorders"},{"issue":"22","key":"10.1016\/bs.irn.2019.10.004_bib135","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2169\/internalmedicine.50.5954","article-title":"PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage","volume":"50","author":"Kurata","year":"2011","journal-title":"Internal Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib136","doi-asserted-by":"crossref","first-page":"e0136575","DOI":"10.1371\/journal.pone.0136575","article-title":"Involvement of peripheral nerves in the transgenic PLP-\u03b1-syn model of multiple system atrophy: Extending the phenotype","volume":"10","author":"Kuzdas-Wood","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib137","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","article-title":"EFNS guidelines on the diagnosis and management of orthostatic hypotension","volume":"13","author":"Lahrmann","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/NPT.0b013e3181b511f4","article-title":"Challenge-oriented gait and balance training in sporadic olivopontocerebellar atrophy: A case study","volume":"33","author":"Landers","year":"2009","journal-title":"Journal of Neurologic Physical Therapy"},{"key":"10.1016\/bs.irn.2019.10.004_bib139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.05.004","article-title":"Fluid biomarkers in multiple system atrophy: A review of the MSA biomarker initiative","volume":"80","author":"Laurens","year":"2015","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.parkreldis.2004.04.008","article-title":"Comparison of magnetic resonance imaging in subtypes of multiple system atrophy","volume":"10","author":"Lee","year":"2004","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib141","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib142","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma \u03b1-synuclein levels in patients with Parkinson's disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"Journal of Neural Transmission"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib143","first-page":"2238","article-title":"Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T","volume":"26","author":"Lee","year":"2005","journal-title":"AJNR American Journal of Neuroradiology."},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JPD-171237","article-title":"LRRK2 p.Ile1371Val mutation in a case with neuropathologically confirmed multi-system Atrophy","volume":"8","author":"Lee","year":"2018","journal-title":"Journal of Parkinson's Disease"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.parkreldis.2012.12.002","article-title":"Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: A longitudinal study","volume":"19","author":"Lee","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib146","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1474-4422(19)30141-3","article-title":"Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): A randomised, double-blind, placebo-controlled trial","volume":"18","author":"Levin","year":"2019","journal-title":"The Lancet Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib147","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mds.26220","article-title":"Minimal change multiple system atrophy: An aggressive variant?","volume":"30","author":"Ling","year":"2015","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib148","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.25847","article-title":"Multiple system atrophy of the cerebellar type: Clinical state of the art","volume":"29","author":"Lin","year":"2014","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib149","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archneurol.2009.71","article-title":"Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure","volume":"66","author":"Lipp","year":"2009","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib150","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: A prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib151","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(13)70301-6","article-title":"Efficacy and safety of rifampicin for multiple system atrophy: A randomised, double-blind, placebo-controlled trial","volume":"13","author":"Low","year":"2014","journal-title":"The Lancet Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib152","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","article-title":"Cerebrospinal fluid biomarkers in parkinsonian conditions: An update and future directions","volume":"85","author":"Magdalinou","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib153","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib154","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000314495","article-title":"Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease","volume":"7","author":"Mahlknecht","year":"2010","journal-title":"Neurodegenerative Diseases"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib155","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/WNL.0000000000001265","article-title":"Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD","volume":"84","author":"Mahlknecht","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib156","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2017.10.020","article-title":"MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP","volume":"46","author":"Mangesius","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"14","key":"10.1016\/bs.irn.2019.10.004_bib157","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/mds.24968","article-title":"Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy","volume":"27","author":"Massey","year":"2012","journal-title":"Movement Disorders"},{"issue":"6543","key":"10.1016\/bs.irn.2019.10.004_bib158","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.293.6543.353","article-title":"The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure","volume":"293","author":"Mathias","year":"1986","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib159","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10286-017-0500-0","article-title":"First symptoms in multiple system atrophy","volume":"28","author":"McKay","year":"2018","journal-title":"Clinical Autonomic Research"},{"key":"10.1016\/bs.irn.2019.10.004_bib160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2016.01.005","article-title":"Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature","volume":"24","author":"Meissner","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib161","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.55.1.84","article-title":"Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases","volume":"55","author":"Mesholam","year":"1998","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib162","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","article-title":"(18)F-FDG PET in parkinsonism: Differential diagnosis and evaluation of cognitive impairment","volume":"58","author":"Meyer","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib163","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: A clinicopathological study","volume":"142","author":"Miki","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib164","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"Journal of Neural Transmission"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: A cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib166","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40478-019-0730-6","article-title":"Understanding the pathogenesis of multiple system atrophy: State of the art and future perspectives","volume":"7","author":"Monzio Compagnoni","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib167","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.13068","article-title":"Available and future treatments for atypical parkinsonism. A systematic review","volume":"25","author":"Moretti","year":"2019","journal-title":"CNS Neuroscience and Therapeutics"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib168","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1054\/jocn.2001.1071","article-title":"Olfactory function in parkinsonian syndromes","volume":"9","author":"Muller","year":"2002","journal-title":"Journal of Clinical Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib169","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s004150200009","article-title":"Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia","volume":"249","author":"Muller","year":"2002","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp.71.4.565","article-title":"\"Hot cross bun\" sign in a patient with parkinsonism secondary to presumed vasculitis","volume":"71","author":"Muqit","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib171","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.55.10.1348","article-title":"Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6","volume":"55","author":"Murata","year":"1998","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib172","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple-system atrophy","volume":"369","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib173","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01826052","article-title":"Environmental-occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation","volume":"1","author":"Nee","year":"1991","journal-title":"Clinical Autonomic Research"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib174","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1148\/radiol.2393050459","article-title":"MR imaging of middle cerebellar peduncle width: Differentiation of multiple system atrophy from Parkinson disease","volume":"239","author":"Nicoletti","year":"2006","journal-title":"Radiology"},{"issue":"Pt 10","key":"10.1016\/bs.irn.2019.10.004_bib175","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/brain\/awl166","article-title":"Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy","volume":"129","author":"Nicoletti","year":"2006","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib176","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mdc3.12446","article-title":"Topography of dopamine transporter availability in the cerebellar variant of multiple system atrophy","volume":"4","author":"Nocker","year":"2017","journal-title":"Movement disorders clinical practice"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib177","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.03.008","article-title":"Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy","volume":"247","author":"Nonaka","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib178","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10286-015-0280-3","article-title":"Multiple system atrophy: The case for an international collaborative effort","volume":"25","author":"Norcliffe-Kaufmann","year":"2015","journal-title":"Clinical Autonomic Research"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib179","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"issue":"Pt 3","key":"10.1016\/bs.irn.2019.10.004_bib180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal \u03b1-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2019.10.004_bib181","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2017.12.001","article-title":"Abnormal pain perception in patients with multiple system atrophy","volume":"48","author":"Ory-Magne","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"15","key":"10.1016\/bs.irn.2019.10.004_bib182","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/mds.22826","article-title":"A validation exercise on the new consensus criteria for multiple system atrophy","volume":"24","author":"Osaki","year":"2009","journal-title":"Movement Disorders"},{"issue":"Pt 12","key":"10.1016\/bs.irn.2019.10.004_bib183","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib184","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/jnnp.2009.182576","article-title":"The phenotype spectrum of Japanese multiple system atrophy","volume":"81","author":"Ozawa","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2019.10.004_bib185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib186","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/mds.21204","article-title":"Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy","volume":"22","author":"Paviour","year":"2007","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib187","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/mds.22440","article-title":"Diffusion-weighted imaging in multiple system atrophy: A comparison between clinical subtypes","volume":"24","author":"Pellecchia","year":"2009","journal-title":"Movement Disorders"},{"issue":"7706","key":"10.1016\/bs.irn.2019.10.004_bib188","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological \u03b1-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib189","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mds.27307","article-title":"MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy","volume":"33","author":"Peran","year":"2018","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.12145","article-title":"Current concepts in the treatment of multiple system Atrophy","volume":"2","author":"Perez-Lloret","year":"2015","journal-title":"Movement disorders clinical practice"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib191","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/mds.25115","article-title":"Multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch","volume":"27","author":"Petrovic","year":"2012","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib192","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","article-title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients","volume":"112","author":"Plotkin","year":"2005","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib193","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(14)70288-1","article-title":"Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial","volume":"14","author":"Poewe","year":"2015","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.irn.2019.10.004_bib194","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"16","key":"10.1016\/bs.irn.2019.10.004_bib195","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.0b013e318250d7fd","article-title":"Network correlates of disease severity in multiple system atrophy","volume":"78","author":"Poston","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib196","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib197","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/bs.irn.2019.10.004_bib198","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","article-title":"Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder","volume":"72","author":"Postuma","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib199","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp.58.5.618","article-title":"Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy","volume":"58","author":"Pramstaller","year":"1995","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2019.10.004_bib200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.52.Suppl.78","article-title":"Multiple system atrophy--the nature of the beast","volume":"Suppl","author":"Quinn","year":"1989","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib201","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1353-8020(97)00022-9","article-title":"Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy","volume":"3","author":"Rajrut","year":"1997","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib202","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/WCO.0000000000000581","article-title":"Progressive supranuclear palsy and multiple system atrophy: Clinicopathological concepts and therapeutic challenges","volume":"31","author":"Respondek","year":"2018","journal-title":"Current Opinion in Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","article-title":"\u03b1-synuclein transfers from neurons to oligodendrocytes","volume":"62","author":"Reyes","year":"2014","journal-title":"Glia"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib204","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/mds.27710","article-title":"Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation","volume":"34","author":"Riboldi","year":"2019","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.autneu.2017.10.006","article-title":"Symptomatic therapy of multiple system atrophy","volume":"211","author":"Rohrer","year":"2018","journal-title":"Autonomic Neuroscience"},{"key":"10.1016\/bs.irn.2019.10.004_bib206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and parkinsonian syndromes: Current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"15","key":"10.1016\/bs.irn.2019.10.004_bib207","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib208","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/neup.12381","article-title":"Perirhinal accumulation of neuronal \u03b1-synuclein in a multiple system atrophy patient with dementia","volume":"37","author":"Saito","year":"2017","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib209","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.68.1.65","article-title":"Urinary dysfunction and orthostatic hypotension in multiple system atrophy: Which is the more common and earlier manifestation?","volume":"68","author":"Sakakibara","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10286-003-0052-3","article-title":"The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria","volume":"13","author":"Sakakibara","year":"2003","journal-title":"Clinical Autonomic Research"},{"key":"10.1016\/bs.irn.2019.10.004_bib211","article-title":"Bladder dysfunction as the initial presentation of multiple system atrophy: A prospective cohort study","author":"Sakakibara","year":"2018","journal-title":"Clinical Autonomic Research"},{"key":"10.1016\/bs.irn.2019.10.004_bib212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-6606-4-24","article-title":"Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: Discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy","volume":"4","author":"Sasaki","year":"2011","journal-title":"Molecular Brain"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib213","first-page":"371","article-title":"Loss of 123I-MIBG uptake by the heart in Parkinson's disease: Assessment of cardiac sympathetic denervation and diagnostic value","volume":"40","author":"Satoh","year":"1999","journal-title":"Journal of Nuclear Medicine"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.004_bib214","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/WNL.0000000000002518","article-title":"Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism","volume":"86","author":"Scherfler","year":"2016","journal-title":"Neurology"},{"issue":"Pt 7","key":"10.1016\/bs.irn.2019.10.004_bib215","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/brain\/awh485","article-title":"Voxel-wise analysis of [123I]\u03b2-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease","volume":"128","author":"Scherfler","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib216","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ene.12753","article-title":"Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature","volume":"23","author":"Schneider","year":"2016","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib217","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/WNL.58.4.575","article-title":"Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD","volume":"58","author":"Schocke","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib218","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.21428","article-title":"Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease","volume":"22","author":"Schoffer","year":"2007","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib219","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","article-title":"SNCA variants are associated with increased risk for multiple system atrophy","volume":"65","author":"Scholz","year":"2009","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mds.20808","article-title":"Health-related quality of life in multiple system atrophy","volume":"21","author":"Schrag","year":"2006","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib221","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.54.3.697","article-title":"Differentiation of atypical parkinsonian syndromes with routine MRI","volume":"54","author":"Schrag","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib222","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00259-004-1465-5","article-title":"The dopamine D2 receptor ligand 18F-desmethoxyfallypride: An appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism","volume":"31","author":"Schreckenberger","year":"2004","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.irn.2019.10.004_bib223","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fninf.2017.00023","article-title":"Multivariate analysis of (18)F-DMFP PET data to assist the diagnosis of parkinsonism","volume":"11","author":"Segovia","year":"2017","journal-title":"Frontiers in Neuroinformatics"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.004_bib224","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.63.8.1154","article-title":"Topography of dopamine transporter availability in progressive supranuclear palsy: A voxelwise [123I]\u03b2-CIT SPECT analysis","volume":"63","author":"Seppi","year":"2006","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib225","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/mds.20229","article-title":"Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease","volume":"19","author":"Seppi","year":"2004","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib226","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/01.WNL.0000049911.91657.9D","article-title":"Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy","volume":"60","author":"Seppi","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroimage.2005.12.006","article-title":"Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study","volume":"31","author":"Seppi","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/bs.irn.2019.10.004_bib228","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2014.12.007","article-title":"Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation","volume":"587","author":"Shao","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib229","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.genhosppsych.2005.08.003","article-title":"Electroconvulsive therapy for the treatment of multiple system atrophy with major depression","volume":"28","author":"Shioda","year":"2006","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/bs.irn.2019.10.004_bib231","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archneur.1960.03840110025004","article-title":"A neurological syndrome associated with orthostatic hypotension: A clinical-pathologic study","volume":"2","author":"Shy","year":"1960","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib232","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib233","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neulet.2009.10.036","article-title":"Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate?","volume":"467","author":"Silveira-Moriyama","year":"2009","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib234","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.22688","article-title":"Hyposmia in progressive supranuclear palsy","volume":"25","author":"Silveira-Moriyama","year":"2010","journal-title":"Movement Disorders"},{"issue":"19","key":"10.1016\/bs.irn.2019.10.004_bib235","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.0b013e3181a55fd2","article-title":"Hyposmia in pure autonomic failure","volume":"72","author":"Silveira-Moriyama","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib236","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1212\/WNL.0000000000003737","article-title":"Pure autonomic failure: Predictors of conversion to clinical CNS involvement","volume":"88","author":"Singer","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib237","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1212\/WNL.0000000000007720","article-title":"Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy","volume":"93","author":"Singer","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib238","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","article-title":"p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy","volume":"171","author":"Song","year":"2007","journal-title":"American Journal Of Pathology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib239","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib240","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.27018","article-title":"REM sleep behavior disorder in Parkinson's disease and other synucleinopathies","volume":"32","author":"St Louis","year":"2017","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib241","series-title":"Neuropsychiatric symptoms of movement disorders","first-page":"141","article-title":"Neuropsychiatric manifestations in atypical parkinsonian syndromes","author":"Stankovic","year":"2015"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib242","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS\u00a0multiple system atrophy (MODIMSA) study group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.004_bib243","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/mds.27701","article-title":"A critique of the second consensus criteria for multiple system atrophy","volume":"34","author":"Stankovic","year":"2019","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib244","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","article-title":"Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human \u03b1-synuclein under oligodendrocyte promoter: Implications for multiple system atrophy","volume":"124","author":"Stefanova","year":"2012","journal-title":"Acta Neuropathologica"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"American Journal of Pathology"},{"key":"10.1016\/bs.irn.2019.10.004_bib246","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2377-11-157","article-title":"The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy","volume":"11","author":"Suzuki","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib247","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","article-title":"Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis","volume":"9","author":"Tang","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib248","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","article-title":"Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone","volume":"232","author":"Ten Harkel","year":"1992","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib249","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mds.1101","article-title":"Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy","volume":"16","author":"Thobois","year":"2001","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02444007","article-title":"Pain in multiple system atrophy","volume":"243","author":"Tison","year":"1996","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.004_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002817.pub4","article-title":"Physiotherapy versus placebo or no intervention in Parkinson's disease","author":"Tomlinson","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib252","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.clineuro.2011.09.004","article-title":"Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis","volume":"113","author":"Treglia","year":"2011","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.004_bib253","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2967\/jnumed.115.161992","article-title":"Automated differential diagnosis of early parkinsonism using metabolic brain networks: A validation study","volume":"57","author":"Tripathi","year":"2016","journal-title":"Journal of Nuclear Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib254","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/jnr.22089","article-title":"Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy","volume":"87","author":"Ubhi","year":"2009","journal-title":"Journal of Neuroscience Research"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib255","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","article-title":"Multiple system atrophy: A clinical and neuropathological perspective","volume":"34","author":"Ubhi","year":"2011","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib256","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2967\/jnumed.109.070144","article-title":"Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease","volume":"51","author":"Van Laere","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib257","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","article-title":"Case-control study of multiple system atrophy","volume":"20","author":"Vanacore","year":"2005","journal-title":"Movement Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib258","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/01.WNL.0000145765.19094.94","article-title":"Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease","volume":"63","author":"Varrone","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib259","doi-asserted-by":"crossref","first-page":"e0172145","DOI":"10.1371\/journal.pone.0172145","article-title":"Side effects induced by the acute levodopa challenge in Parkinson's disease and atypical parkinsonisms","volume":"12","author":"Vasta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2019.10.004_bib260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.parkreldis.2019.02.006","article-title":"Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type","volume":"63","author":"Vergnet","year":"2019","journal-title":"Parkinsonism and Related Disorders"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.10.004_bib261","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-510X(00)00429-9","article-title":"Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration","volume":"180","author":"Vogels","year":"2000","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.004_bib262","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S0317167100014360","article-title":"The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders","volume":"40","author":"Wadia","year":"2013","journal-title":"The Canadian Journal of Neurological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib263","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.0000000000004798","article-title":"Recommendations of the global multiple system atrophy research roadmap meeting","volume":"90","author":"Walsh","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.004_bib264","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archneur.64.11.1635","article-title":"Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease","volume":"64","author":"Walter","year":"2007","journal-title":"Archives of Neurology"},{"issue":"48","key":"10.1016\/bs.irn.2019.10.004_bib265","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib266","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1519\/00139143-200831020-00007","article-title":"The impact of resistance training on balance and functional ability of a patient with multiple system atrophy","volume":"31","author":"Wedge","year":"2008","journal-title":"Journal of Geriatric Physical Therapy"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib267","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.wnf.0000183240.47960.f0","article-title":"Placebo-controlled trial of amantadine in multiple-system atrophy","volume":"28","author":"Wenning","year":"2005","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/bs.irn.2019.10.004_bib268","series-title":"Movement disorders in neurologic and systemic disease","first-page":"363","article-title":"Dysautonomia in movement disorders","author":"Wenning GF","year":"2013"},{"issue":"Pt 4","key":"10.1016\/bs.irn.2019.10.004_bib269","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"Wenning","year":"1995","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib271","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O","article-title":"Progression of falls in postmortem-confirmed parkinsonian disorders","volume":"14","author":"Wenning","year":"1999","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: A prospective European cohort study","author":"Wenning","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"Suppl. 12","key":"10.1016\/bs.irn.2019.10.004_bib273","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1002\/mds.20543","article-title":"Therapeutic strategies in multiple system atrophy","volume":"20","author":"Wenning","year":"2005","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.004_bib274","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","article-title":"Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study","volume":"67","author":"Wenning","year":"1999","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.004_bib275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1995.tb06998.x","article-title":"Olfactory function in atypical parkinsonian syndromes","volume":"91","author":"Wenning","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.004_bib276","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: A review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.004_bib277","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.004_bib278","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: A retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib279","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.2003.025155","article-title":"Probable multiple system atrophy in a German family","volume":"75","author":"Wullner","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2019.10.004_bib280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.irn.2018.09.001","article-title":"PET molecular imaging in atypical parkinsonism","volume":"142","author":"Xu","year":"2018","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2019.10.004_bib281","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neulet.2014.10.046","article-title":"The utility of susceptibility-weighted imaging for differentiating parkinsonism-predominant multiple system atrophy from Parkinson's disease: Correlation with 18F-flurodeoxyglucose positron-emission tomography","volume":"584","author":"Yoon","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.004_bib282","doi-asserted-by":"crossref","first-page":"e00329","DOI":"10.1002\/brb3.329","article-title":"Patterns of gray matter atrophy in atypical parkinsonism syndromes: A VBM meta-analysis","volume":"5","author":"Yu","year":"2015","journal-title":"Brain and Behavior"},{"issue":"Pt 8","key":"10.1016\/bs.irn.2019.10.004_bib283","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/brain\/awv138","article-title":"Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy","volume":"138","author":"Zange","year":"2015","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2019.10.004_bib284","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2017.03.001","article-title":"White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study","volume":"39","author":"Zanigni","year":"2017","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.004_bib285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.parkreldis.2019.08.007","article-title":"Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease","volume":"66","author":"Zhang","year":"2019","journal-title":"Parkinsonism & Related Disorders"}],"container-title":["International Review of Neurobiology","Parkinsonism Beyond Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421930090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421930090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:13:43Z","timestamp":1758748423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477421930090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177303"],"references-count":285,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2019.10.004","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}